Forsyth Medical Center 
Cancer Research
Colorectal and Gastrointestinal Cancer Clinical Trials
| We are currently participating in several clinical trials for colorectal and gastrointestinal cancers. |
 |
||
|
Want To Participate?
If you or someone you know may be interested in participating in a clinical trial, contact us at dmccall@phoa.org or (336) 277-8887.
|
|
|
||
Colorectal
USO 04-062:AVANT STUDY, PHASE III, OXALIPLATIN & 5FU WITH OR WITHOUT AVASTIN VERSUS XELODA ,OXALIPLATIN & AVASTIN FOR HIGH RISK STAGE II & III , ADJUVANT
CA225006: PHASE III, CPT-11 & ERBITUX VERSUS CPT-11 FOR EGFR+ AND HAVE FAILED OXALIPLATIN 2ND LINE METASTATIC
USO 05009:PACE STUDY, PHASE III, AVASTIN, OXALIPLATIN & 5FU ( FOLFOX) VERSUS AVASTIN, OXALIPLATIN & 5FU + PANITUMUMAB FOR 1ST LINE METASTATIC
Gastrointestinal Stromal Tumor
CTSU Z9001: GLEEVEC VERSUS PLACEBO AFTER COMPLETE RESECTION
